GGrantIndex
← Search

PHASE I STUDY OF INTRATHECAL GEMCITABINE IN PATIENTS WITH REFRACTORY MALIGNANCY

$6,514M01FY2006RRNIH

Baylor College Of Medicine, Houston TX

Investigators

Linked publications & trials

View original record on NIH RePORTER →